Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionStock Option (right to buy) · Derivative | 48,144 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · derivative · entry 8 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,346 Underlying: Common Stock · 48,144 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionStock Option (right to buy) · Derivative | 34,680 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · derivative · entry 7 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,680 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionStock Option (right to buy) · Derivative | 53,040 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · derivative · entry 6 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,040 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
SaleCommon Stock | 135,864 | $58.56 | $7,956,372.46 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · nonDerivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,230.2077 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.4000 to $58.7900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 34,680 | $44.19 | $1,532,509.20 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · nonDerivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,094.2077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 48,144 | $33.49 | $1,612,342.56 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,414.2077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2015 Filed Feb 11, 2015 19:19 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 53,040 | $44.30 | $2,349,672.00 |
DisclosureSEC source: 0001225208-15-003523 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,270.2077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2015 Filed Feb 9, 2015 20:24 UTC |
Wendell Peter CDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-15-003213 · doc4.xml · derivative · entry 3 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008. Read SEC document |
| February 09, 2015 Filed Feb 9, 2015 20:24 UTC |
Wendell Peter CDirector
|
SaleCommon Stock | 5,000 | $58.76 | $293,797.00 |
DisclosureSEC source: 0001225208-15-003213 · doc4.xml · nonDerivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.7200 to $58.8500 inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| February 09, 2015 Filed Feb 9, 2015 20:24 UTC |
Wendell Peter CDirector
|
Exercise / conversionCommon Stock | 5,000 | $33.83 | $169,150.00 |
DisclosureSEC source: 0001225208-15-003213 · doc4.xml · nonDerivative · entry 1 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2015 Filed Feb 11, 2015 22:25 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantRestricted Stock Unit · Derivative | 8,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-003596 · doc4.xml · derivative · entry 3 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,572 Underlying: Common Stock · 8,572 shares Expires 2018-02-09 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,200 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · derivative · entry 8 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,200 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · derivative · entry 7 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.47 | $0.00 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · derivative · entry 6 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 2/1/2007, 2/1/2008 and 2/1/2009. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
SaleCommon Stock | 74,200 | $62.48 | $4,636,223.76 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · nonDerivative · entry 4 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.1200 to $62.9800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 5,000 | $34.47 | $172,350.00 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · nonDerivative · entry 3 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 19,200 | $35.09 | $673,728.00 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2015 Filed Jan 15, 2015 20:55 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionCommon Stock | 50,000 | $44.19 | $2,209,500.00 |
DisclosureSEC source: 0001225208-15-001415 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2015 Filed Jan 9, 2015 19:44 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,333 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-15-001128 · doc4.xml · derivative · entry 6 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,666 Underlying: Common Stock · 9,333 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009. Read SEC document |
| January 09, 2015 Filed Jan 9, 2015 19:44 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,541 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-15-001128 · doc4.xml · derivative · entry 5 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,082 Underlying: Common Stock · 3,541 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 2/25/2006, 2/25/2007 and 2/25/2008. Read SEC document |
| January 09, 2015 Filed Jan 9, 2015 19:44 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 8,840 | $62.47 | $552,266.62 |
DisclosureSEC source: 0001225208-15-001128 · doc4.xml · nonDerivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,482.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.1900 to $62.7000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| January 09, 2015 Filed Jan 9, 2015 19:44 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 3,541 | $31.84 | $112,745.44 |
DisclosureSEC source: 0001225208-15-001128 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,322.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2015 Filed Jan 9, 2015 19:44 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 9,333 | $35.09 | $327,494.97 |
DisclosureSEC source: 0001225208-15-001128 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,781.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2014 Filed Jan 2, 2015 18:54 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 638.3166 | $56.79 | $36,250.00 |
DisclosureSEC source: 0001225208-15-000054 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,755.9273 Underlying: Common Stock · 638.3166 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2014 Filed Jan 2, 2015 18:57 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 440.2183 | $56.79 | $25,000.00 |
DisclosureSEC source: 0001225208-15-000055 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,846.6657 Underlying: Common Stock · 440.2183 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2014 Filed Jan 2, 2015 19:00 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 484.2402 | $56.79 | $27,500.00 |
DisclosureSEC source: 0001225208-15-000056 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,763.9123 Underlying: Common Stock · 484.2402 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2014 Filed Jan 2, 2015 19:01 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 440.2183 | $56.79 | $25,000.00 |
DisclosureSEC source: 0001225208-15-000057 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,938.4387 Underlying: Common Stock · 440.2183 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 10, 2014 Filed Dec 10, 2014 22:59 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,333 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-14-024749 · doc4.xml · derivative · entry 6 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,999 Underlying: Common Stock · 9,333 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009. Read SEC document |
| December 10, 2014 Filed Dec 10, 2014 22:59 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,541 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-14-024749 · doc4.xml · derivative · entry 5 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,623 Underlying: Common Stock · 3,541 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 2/25/2006, 2/25/2007 and 2/25/2008. Read SEC document |
| December 10, 2014 Filed Dec 10, 2014 22:59 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 9,846 | $60.00 | $590,760.00 |
DisclosureSEC source: 0001225208-14-024749 · doc4.xml · nonDerivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,448.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 10, 2014 Filed Dec 10, 2014 22:59 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 3,541 | $31.84 | $112,745.44 |
DisclosureSEC source: 0001225208-14-024749 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,294.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2014 Filed Dec 10, 2014 22:59 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 9,333 | $35.09 | $327,494.97 |
DisclosureSEC source: 0001225208-14-024749 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,753.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2014 Filed Dec 8, 2014 23:55 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $51.02 | $0.00 |
DisclosureSEC source: 0001225208-14-024549 · doc4.xml · derivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2017-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable in equal installments on 8/1/2008, 8/1/2009 and 8/1/2010. Read SEC document |
| December 08, 2014 Filed Dec 8, 2014 23:55 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
SaleCommon Stock | 50,000 | $62.00 | $3,100,000.00 |
DisclosureSEC source: 0001225208-14-024549 · doc4.xml · nonDerivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,467.496 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 08, 2014 Filed Dec 8, 2014 23:55 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 50,000 | $51.02 | $2,551,000.00 |
DisclosureSEC source: 0001225208-14-024549 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,467.496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2014 Filed Nov 26, 2014 17:40 UTC |
LAZARUS ROCHELLE BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-14-024069 · doc4.xml · derivative · entry 6 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008. Read SEC document |
| November 26, 2014 Filed Nov 26, 2014 17:40 UTC |
LAZARUS ROCHELLE BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.44 | $0.00 |
DisclosureSEC source: 0001225208-14-024069 · doc4.xml · derivative · entry 5 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009. Read SEC document |
| November 26, 2014 Filed Nov 26, 2014 17:40 UTC |
LAZARUS ROCHELLE BDirector
|
SaleCommon Stock | 10,000 | $59.63 | $596,300.00 |
DisclosureSEC source: 0001225208-14-024069 · doc4.xml · nonDerivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,595 Read SEC document |
| November 26, 2014 Filed Nov 26, 2014 17:40 UTC |
LAZARUS ROCHELLE BDirector
|
Exercise / conversionCommon Stock | 5,000 | $33.83 | $169,150.00 |
DisclosureSEC source: 0001225208-14-024069 · doc4.xml · nonDerivative · entry 2 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2014 Filed Nov 26, 2014 17:40 UTC |
LAZARUS ROCHELLE BDirector
|
Exercise / conversionCommon Stock | 5,000 | $34.44 | $172,200.00 |
DisclosureSEC source: 0001225208-14-024069 · doc4.xml · nonDerivative · entry 1 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2014 Filed Nov 25, 2014 23:57 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
SalePhantom Stock · Derivative | 2,778.88 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-14-024001 · doc4.xml · derivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,778.88 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program. F1 · shares: Holdings include shares acquired in dividend reinvestment transactions. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program. Read SEC document |
| November 24, 2014 Filed Nov 26, 2014 00:08 UTC |
WEEKS WENDELL PDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-14-024003 · doc4.xml · derivative · entry 5 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008. Read SEC document |
| November 24, 2014 Filed Nov 26, 2014 00:08 UTC |
WEEKS WENDELL PDirector
|
SaleCommon Stock | 3,200 | $59.13 | $189,229.12 |
DisclosureSEC source: 0001225208-14-024003 · doc4.xml · nonDerivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Read SEC document |
| November 24, 2014 Filed Nov 26, 2014 00:08 UTC |
WEEKS WENDELL PDirector
|
SaleCommon Stock | 1,800 | $59.13 | $106,434.00 |
DisclosureSEC source: 0001225208-14-024003 · doc4.xml · nonDerivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,300 Read SEC document |
| November 24, 2014 Filed Nov 26, 2014 00:08 UTC |
WEEKS WENDELL PDirector
|
Exercise / conversionCommon Stock | 5,000 | $33.83 | $169,150.00 |
DisclosureSEC source: 0001225208-14-024003 · doc4.xml · nonDerivative · entry 1 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2014 Filed Nov 10, 2014 21:36 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,333 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001225208-14-023001 · doc4.xml · derivative · entry 6 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,332 Underlying: Common Stock · 9,333 shares Expires 2016-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009. Read SEC document |
| November 10, 2014 Filed Nov 10, 2014 21:36 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,542 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001225208-14-023001 · doc4.xml · derivative · entry 5 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,164 Underlying: Common Stock · 3,542 shares Expires 2015-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 2/25/2006, 2/25/2007 and 2/25/2008. Read SEC document |
| November 10, 2014 Filed Nov 10, 2014 21:36 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 10,000 | $57.98 | $579,784.00 |
DisclosureSEC source: 0001225208-14-023001 · doc4.xml · nonDerivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,420.063 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.7100 to $58.2300, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 10, 2014 Filed Nov 10, 2014 21:36 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 3,542 | $31.84 | $112,777.28 |
DisclosureSEC source: 0001225208-14-023001 · doc4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,420.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2014 Filed Nov 10, 2014 21:36 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 9,333 | $35.09 | $327,494.97 |
DisclosureSEC source: 0001225208-14-023001 · doc4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,878.063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.